TELA Bio (TELA) Share-based Compensation (2018 - 2026)

TELA Bio's Share-based Compensation history runs 9 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• On a quarterly basis, Share-based Compensation rose 206.51% year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $3.2 million, a 55.67% decrease from a year earlier, with the FY2025 full-year figure at $3.8 million, down 12.98% from the prior year.
• Share-based Compensation climbed to $3.2 million in Q1 2026 per TELA's latest filing, from $812000.0 in the prior quarter.
• Across five years, Share-based Compensation topped out at $4.0 million in Q4 2024 and bottomed at $153000.0 in Q1 2022.
• The 5-year median for Share-based Compensation is $1.1 million (2024), against an average of $1.3 million.
• Across the five-year window, Share-based Compensation soared 637.25% in 2023 and plunged 79.72% in 2025, its largest moves.
• Year by year, Share-based Compensation stood at $1.0 million in 2022, then tumbled by 40.6% to $610000.0 in 2023, then jumped by 556.39% to $4.0 million in 2024, then plunged by 79.72% to $812000.0 in 2025, then jumped by 294.09% to $3.2 million in 2026.
• Per Business Quant, the three latest TELA Share-based Compensation figures stand at $3.2 million (Q1 2026), $812000.0 (Q4 2025), and $955000.0 (Q3 2025).